FPWR funds often help investigators develop a new line of research, obtaining the preliminary results needed to compete for larger, multi-year grants from the NIH and other organizations. Many of our researchers have been awarded these larger grants as a result of FPWR’s seed investment and support.
Investigator: James Hougland, PhD
FPWR Grant: Development and validation of ghrelin O-acyltransferase inhibitors for treating hyperphagia in Prader-Willi syndrome
American Diabetes Association: Targeting ghrelin acylation for control of glucose homeostasis ($414,000).
The Foundation for Prader-Willi Research (federal tax id 31-1763110) is a nonprofit corporation with federal tax exempt status as a public charity under section 501(c)(3).
The mission of FPWR is to eliminate the challenges of Prader-Willi syndrome through the advancement of research. High-quality research will lead to more effective treatments and an eventual cure for this disorder. By working together, we intend to free our loved ones from the burdens of PWS, allowing them to lead full and independent lives.
Foundation for Prader-Willi Research
340 S. Lemon Ave, #3620
Walnut, CA 91789